Enlivex to Use Blockchain Tokens in Treasury
Update: 2025-11-24
Description
Enlivex Therapeutics, an Israeli biotech company, is set to become the first U.S. publicly traded firm to use a blockchain-based prediction markets token as its main treasury reserve asset. They plan to raise $212 million through a private placement, using the majority of these funds to purchase RAIN tokens, a prediction markets token on the Arbitrum blockchain. Enlivex will continue its clinical trials for Allocetra, a macrophage therapy for osteoarthritis, and former Italian prime minister Matteo Renzi is expected to join their board. The private placement is priced at $1 per share, reflecting strong investor confidence in this innovative financial strategy.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
